Organon & Co. (OGN)

Pharmaceutical Preparations · Healthcare · $3.8B

overvalued
Intrinsic Value (Consensus)
$9.40
Current Price
$14.40
Margin of Safety
-34.7%
34.7% Above Intrinsic Value
Value: $9
Price: $14

Valuation Model Estimates

Current Price: $14.40
DCF (Discounted Cash Flow)
$25.97
Graham Number
$6.81
Earnings Power Value
$6.99
Relative Value (P/E)
$14.40
Dividend Discount Model
$0.24
Consensus Value
$9.40

Model Assumptions

Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$0.72
EPS (Forward)
$0.73
Book Value
$2.86
P/E Ratio
20.0
Forward P/E
19.6
PEG Ratio
ROE
24.9%
Debt/Equity
1149%
Revenue Growth
-2.9%
Earnings Growth
2.0%
Dividend Yield
0.1%
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance